ITMCTR2100004469尚未招募1 期

Clinical effect of wet application of tripterygium wilfordii granules on psoriasis vulgaris

Yueyang integrated traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

阶段: 1 期
状态: 尚未招募
发起方

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional study

入排标准

性别: All

入选标准

•The results were as follows: 1. The patients who met the diagnostic criteria of psoriasis vulgaris with skin lesion area less than or equal to 10% BSA tended to be aggregated;
•2. Subjects who meet the diagnostic criteria of blood heat syndrome of traditional Chinese medicine;
•3. Subjects aged >= 18 and <= 79 years, regardless of gender;
•4. Patients with informed consent, signed informed consent, discussed through ethics committee, volunteered to receive treatment, observation and examination.

排除标准

•1. Patients with only head and face lesions, patients with scattered lesions such as drip type, and patients with other active skin diseases may affect the condition evaluators;
•2. Patients who received systemic research drugs, biological agents and immunosuppressants within 3 months; He had been treated with glucocorticoid and phototherapy within 2 weeks;
•3. Patients in the period of severe uncontrollable local or systemic acute or chronic infection, patients with history of malignant tumor, patients with primary or secondary immunodeficiency and hypersensitivity, patients with severe systemic diseases, patients with severe mental history or family history, or other abnormal patients judged by researchers not suitable for this trial;
•4. Patients who have undergone major surgery within 8 weeks or who will need such surgery during the study period;
•5. Pregnant or lactating women;
•6. Subjects with a history of alcohol, drug or drug abuse;
•7. Subjects known to be allergic to Tripterygium wilfordii or calcipotriol, and subjects with calcium metabolism disorder;
•8. For other reasons, those subjects that the researchers think are not suitable to participate in this study.

研究者

发起方

Yueyang integrated traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of traditional Chinese Medicine

相似试验

尚未招募

4 期

Efficacy and Safety of Tripterygium hypoglaucum Root Tablet combined with Tacrolimus Therapy in primary membranous nephropathy with moderate risk : a double-blind, randomised, controlled trialprimary membranous nephropathy with moderate risk

ITMCTR2200005596The First Affiliated Hospital, College of Medicine, Zhejiang University

招募中

不适用

Efficacy and Safety of Tripterygium Wilfordii Multiglycosides in Idiopathic Membranous Nephropathy: Protocol for An Open-label Randomized Controlled Clinical Trial

ITMCTR2200005709Department of Nephrology, Sichuan Provincial People's Hospital

已完成

2 期

Evaluation of the subcutaneous administration of 30 mg of S78989 versus placebo and evaluation of the subcutaneous administration of 60mg of S78989 versus placebo, on the reduction of arterial wall inflammation in patients with marked atherosclerotic plaque inflammation. A 28-weeks, randomized, double-blind, parallel-group, placebo controlled, international multicenter exploratory pilot study.arterial wall inflammationartherosclerosis10003216

NL-OMON39440I.R.I.S22

进行中（未招募）

不适用

EUCTR2012-002677-53-NLInstitut de Recherches Internationales Servier (I.R.I.S.)45

进行中（未招募）

不适用

EUCTR2012-002677-53-FIInstitut de Recherches Internationales Servier (I.R.I.S.)90